Entity Details
Primary name |
UBP27_HUMAN |
Entity type |
UniProt |
Source |
Source Link |
Details
Accession | A6NNY8 |
EntryName | UBP27_HUMAN |
FullName | Ubiquitin carboxyl-terminal hydrolase 27 |
TaxID | 9606 |
Evidence | evidence at transcript level |
Length | 438 |
SequenceStatus | complete |
DateCreated | 2007-10-02 |
DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
Subcellular Location |
Cytoplasm |
Nucleus |
Domains
Show/Hide Table
Domain | Name | Category | Type |
IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase | Domain | Domain |
IPR018200 | Ubiquitin specific protease, conserved site | Site | Conserved site |
IPR028889 | Ubiquitin specific protease domain | Domain | Domain |
IPR038765 | Papain-like cysteine peptidase superfamily | Family | Homologous superfamily |
Diseases
Show/Hide Table
Disease ID | Source | Name | Description |
300984 | OMIM | Mental retardation, X-linked 105 (MRX105) | A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. The disease is caused by variants affecting the gene represented in this entry. |
Interactions
4 interactions